News Room

Events & Presentations

Happening This Week

Piper Sandler 33rd Annual Virtual Healthcare Conference
Virtual – Thursday, December 2, 2021 11:30 AM EST – Webcast

Evercore ISI 4th Annual HealthCONx Conference 2021
Virtual – Tuesday, November 30, 2021 9:40 AM EST – Webcast

5th Annual NASH Summit
Virtual – November 29 – December 2, 2021 – Summit Website

November 30th, Becky Taub MD

9:30 am A NASH Drug Development Landscape Post-mortem: Critically Analyzing Lessons Learned from the Past 12 Months of NASH Drug Development Failures to Understand How to Avoid Common Mistakes & Achieve Clinical Success in 2022 & Beyond

1:30 pm Discovering Resmetirom: A Selective Thyroid Hormone Receptor Beta Agonist in Phase 3 Clinical Development for the Treatment of NASH

Upcoming & Recent Events

AASLD The Liver Meeting® 2021
Resmetirom Clinical Data Review – November 16, 2021 – WebcastSlide Deck

HC Wainwright 5th Annual NASH Investor Conference
Virtual – Tuesday, October 12th, 2021

Madrigal and Fatty Liver Foundation Ring Nasdaq Closing Bell to Increase Awareness of NAFLD/NASH
Virtual – October 4th, 2021 – Watch Video

EASL International Liver Congress 2021
Oral Plenary Presentation: Stephen A. Harrison, M.D. – June 25, 2021 – WebcastView Slides

EASL International Liver Congress 2021
Madrigal Hosted Symposium: Stephen A. Harrison, M.D. – June 25, 2021 – WebcastView Slides

EASL International Liver Congress 2021
Poster Abstract – June 23, 2021 – View Poster

JMP Securities Life Sciences Conference
Virtual – Wednesday, June 16, 2021 3:30pm ET – Webcast

42nd Annual Goldman Sachs Global Healthcare Conference
Virtual – Thursday, June 10, 2021 9:40am ET – Webcast

Presentations

MADRIGAL PRESENTS, Resmetirom a leader in NAFLD/NASH drug development

Stephen A. Harrison, M.D. AACE 2021 Presentation

Stephen A. Harrison, M.D. AASLD 2020 Presentation

Seth Baum, M.D. AASLD 2019 Presentation

LDL cholesterol, apolipoprotein B, lipoprotein(a), apolipoprotein CIII and triglyceride lowering by MGL-3196, a thyroid hormone receptor beta selective agonist, in a 12 week study in HeFH patients
August 21, 2018

MGL-3196, a β-Selective Thyroid Hormone Receptor (THR) Agonist, Demonstrates Metabolic, Anti-inflammatory and Anti-fibrotic Benefits in a Long-term High Fat Diet (HFD) Mouse NASH Model
October 20-24, 2017

MRI-PDFF response in MGL-3196 and placebo treated patients predicts reduction in ballooning and inflammation components of NAS and NASH resolution in a 36-week serial liver biopsy study

Archived Events

UBS Global Healthcare Virtual Conference
Virtual – May 24 - 26, 2021

RBC Capital Markets Global Healthcare Conference
Virtual – May 18 - 20, 2021

Piper Sandler Virtual Northeast BioInsights Bus Tour – Fireside Chat
Virtual – May 6, 2021

HC Wainwright Healthcare Conference
Virtual – March 9 – 10, 2021

Cowen 41st Annual Healthcare Conference
Virtual – March 2 – 3, 2021

SVB Leerink 10th Annual Global Healthcare Conference
Virtual – February 25, 2021

Piper Sandler 32nd Annual Virtual Healthcare Conference
Virtual – December 2, 2020

2020 Evercore ISI HealthCONx Conference
Virtual – December 1, 2020

More Archived Events …

2nd Annual Wolfe 2020 Healthcare Conference
Virtual – November 19, 2020

Stifel 2020 Virtual Healthcare Conference
Virtual – November 16, 2020

AASLD The Liver Meeting® 2020
Virtual – November 13, 2020

H.C. Wainwright 4th Annual Nash Investor Conference
Virtual – October 5, 2020

H.C. Wainwright 22nd Annual Global Investment Conference
Virtual – September 14-16, 2020

Citi's 15th Annual BioPharma Virtual Conference
Virtual – September 9 & 10, 2020

EASL The Digital International Liver Congress
Virtual – August 27 – 29, 2020

KOL & MDGL CALL - NASH Therapeutics: Preview to a Long Awaited, Data-Rich Digital EASL’20 HOSTED BY Mayank Mamtani, B Riley
Audio – August 26, 2020

2020 Goldman Sachs Annual East Coast Biotech Bus Tour
Virtual – August 14, 2020

40th Annual Canaccord Genuity Growth Conference
Virtual – August 11-13, 2020

Oppenheimer Fireside Chat – Hot Topics in NASH
Virtual – June 23, 2020

Madrigal Pharmaceuticals, Inc. Annual Stockholders’ Meeting
Virtual – June 17, 2020

Goldman Sachs 41st Annual Global Healthcare Conference
Virtual – 6/9 - 6/11/2020

Jefferies Global Healthcare Conference
Virtual – Tuesday June 2 – Thursday June 4, 2020

RBC Capital Markets 2020 Global Healthcare Conference
Virtual – Wednesday, May 20, 2020

UBS Global Healthcare Conference
Virtual – Tuesday, May 19, 2020

Cowen and Company 40th Annual Health Care Conference
Boston, MA – March 4, 2020

SVB Leerink 9th Annual Global Healthcare Conference
New York, NY – February 26, 2020

NASH-TAG Conference 2020
Deer Valley Resort, Park City, UT – January 10 – 11, 2020

Evercore ISI 2nd Annual HEALTHCONx Conference
Boston, MA – December 3-5, 2019

Stifel Healthcare Conference
New York, NY – November 19-20, 2019

AASLD The Liver Meeting® 2019
Boston, MA – November 11, 2019 1:30pm

AASLD The Liver Meeting® 2019
Boston, MA – November 11, 2019 5:30pm

AASLD The Liver Meeting® 2019
Boston, MA – November 11, 2019 8:00am

Wolfe Healthcare Conference
New York, NY – November 6, 2019

H.C. Wainwright 3rd Annual NASH Investor Conference
New York, NY – October 21, 2019

H.C. Wainwright 21st Annual Global Investment Conference
New York, NY – September 8-10 2019

European Society of Cardiology(ESC)
Paris, France – Saturday 31 August - Wednesday 4 September 2019

5th Paris NASH meeting
Paris, France – July 11, 2019

JMP Securities Life Sciences Conference
New York, NY – June 19 – 20, 2019

Goldman Sachs 40th Annual Global Healthcare Conference
Rancho Palos Verdes, CA – June 11 - 13, 2019

Jefferies 2019 Global Healthcare Conference
New York, NY – June 4 - 7

UBS 2019 Global Healthcare Conference
New York, NY – May 20 – 22, 2019

3rd Annual NASH Summit
Boston, MA – April 22-25 2019

International Liver Congress™ 2019, European Association for the Study of the Liver (EASL)
Vienna – April 11, 2019

Roth NASH Investor Conference
New York, NY – March 28, 2019

Oppenheimer Healthcare Conference
New York, NY – March 19 – 20, 2019

Roth Conference
Laguna Niguel, CA – March 17 – 19, 2019

Cowen Healthcare Conference
Boston, MA – March 11 – 13, 2019

NASH-TAG 2019 Conference
Park City, UT – January 3 – 5, 2019

Citi Global Healthcare Conference
New York, NY – December 5–6, 2018

Evercore ISI 2018 HealthConX Conference
Boston, MA – November 27, 2018

3rd Annual World Preclinical Congress
Lisbon, Portugal – November 27–30, 2018

Evercore ISI Madrigal
Webinar – November 19, 2018

Credit Suisse Annual Healthcare Conference
Scottsdale, AZ – November 14, 2018

AASLD – The Liver Meeting 2018 – Analyst/Investor KOL Event
San Francisco, CA – November 12, 2018

AASLD – The Liver Meeting 2018 – Plenary Presentation
San Francisco, CA – November 12, 2018

NASH Summit Europe 2018
Frankfurt, Germany – October 22–24, 2018

Roth NASH Investor Conference
New York, NY – October 17, 2018

H. C. Wainwright 20th Annual Global Investment Conference
New York, NY – September 4-6, 2018

JMP Securities Life Sciences Conference
New York, NY – June 21, 2018

Goldman Sachs 39th Annual Global Healthcare Conference
Rancho Palos Verdes, California – June 13, 2018

Review of Madrigal’s 36-week phase 2 results for MGL-3196
New York, NY – May 31, 2018 8:30am

EASL International Liver Congress 2018
Paris, France – April 11-15, 2018

HC Wainwright NASH Investor Conference 2018
New York, NY – March 19, 2018

The Cowen and Company 38th Annual Health Care Conference
Boston, MA – March 14th 2018

Global NASH Congress
London, UK – February 26-27, 2018

Madrigal’s MGL-3196 Achieves Primary Endpoint in Patients with Heterozygous Familial Hypercholesterolemia (HeFH)
Conference Call & Webcast – February 8th, 2018

2018 NASH-TAG CONFERENCE
Thyroid Hormone Receptor Agonist – Becky Taub, MD
Park City, Utah – January 4-6, 2018

Madrigal Announces Top-line Results from Phase 2 NASH Clinical Trial
Conference Call & Webcast – December 6 2017 8:30 am ET

Evercore ISI Biopharma Catalyst/Deep Dive Conference
Boston, MA – November 29-30, 2017

Jefferies 2017 London Healthcare Conference
London, UK – November 15-16, 2017

FIRST EASL NAFLD SUMMIT
Vitamin D, thyroid function (the obvious and neglected; including Liver-Directed Thyroid Hormone Receptor-β (THR-β) agonists
Rome, Italy – November 9-11, 2017

AASLD Liver Meeting
Poster # 1969: MGL-3196, a β-Selective Thyroid Hormone Receptor (THR) Agonist, Demonstrates Metabolic, Anti-inflammatory and Anti-fibrotic Benefits in a Long-term High Fat Diet (HFD) Mouse NASH Model
Washington, DC – October 20-24, 2017

Discovery on Target Conference:
Thyroid Hormone Receptor Targets
Boston, MA – September 26, 2017

Cantor Fitzgerald Healthcare Conference
New York, NY – September 25-27, 2017

HC Wainwright / Rodman & Renshaw Annual Healthcare Conference
New York, NY – September 10-12, 2017

JMP Securities Life Sciences Conference
New York, NY – June 20-21, 2017

Jefferies 2017 Healthcare Conference
New York, NY – June 6-9, 2017

Jefferies 2018 Global Healthcare Conference
New York, NY – June 5-8, 2018

H.C. Wainwright NASH Investor Conference
New York, NY – April 3, 2017

ROTH Investor Conference
Laguna Niguel, CA – March 13, 2017

Cowen Healthcare Conference
Boston, MA – March 8, 2017